Transcutaneous Vagus Nerve Stimulation Could Improve the Effective Rate on the Quality of Sleep in the Treatment of Primary Insomnia: A Randomized Control Trial
- PMID: 36291230
- PMCID: PMC9599790
- DOI: 10.3390/brainsci12101296
Transcutaneous Vagus Nerve Stimulation Could Improve the Effective Rate on the Quality of Sleep in the Treatment of Primary Insomnia: A Randomized Control Trial
Abstract
(1) Background: The purpose of this study was to investigate the efficacy and safety of transcutaneous vagus nerve stimulation (t-VNS) in the treatment of primary insomnia. (2) Methods: This is a single center, randomized, double-blind study. A total of 30 patients diagnosed with primary insomnia were randomly divided into two groups to receive 20 Hz t-VNS in either the auricular concha area (treatment group) or periauricular area (control group), twice a day for 20 min during a one-month study period. The effective rate of treatment, defined as a ≥50% reduction of the Pittsburgh Sleep Index Scale (PSQI) after treatment, was compared between the two groups as the primary outcome. Response rate (defined as ≥10% change in the PSQI score), and changes in the Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) scores were also assessed. (3) Results: After one month of treatment, the PSQI score of the treatment group decreased significantly (p = 0.001). The effective rate of the treatment group (73% vs. 27%, p = 0.027) was significantly higher than that of the control group. No statistical differences in changes of HAMA and HAMD scores were detected between the two groups. There were no complications in all patients. (4) Conclusion: T-VNS appeared to be a safe and effective treatment for primary insomnia.
Keywords: Pittsburgh Sleep Index; anxiety; depression; primary insomnia; transcutaneous vagus nerve stimulation.
Conflict of interest statement
The authors declare no conflict of interests.
Figures



Similar articles
-
Effect of Transcutaneous Vagus Nerve Stimulation at Auricular Concha for Insomnia: A Randomized Clinical Trial.Evid Based Complement Alternat Med. 2020 Aug 6;2020:6049891. doi: 10.1155/2020/6049891. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32831871 Free PMC article.
-
[Transcutaneous vagus nerve stimulation for primary insomnia and affective disorder:a report of 35 cases].Zhongguo Zhen Jiu. 2017 Mar 12;37(3):269-273. doi: 10.13703/j.0255-2930.2017.03.013. Zhongguo Zhen Jiu. 2017. PMID: 29231433 Chinese.
-
Transcutaneous Vagus Nerve Stimulation for Insomnia in People Living in Places or Cities with High Altitudes: A Randomized Controlled Trial.Brain Sci. 2023 Jun 22;13(7):985. doi: 10.3390/brainsci13070985. Brain Sci. 2023. PMID: 37508917 Free PMC article.
-
Transcutaneous Vagus Nerve Stimulation (t-VNS) and epilepsy: A systematic review of the literature.Seizure. 2021 Oct;91:40-48. doi: 10.1016/j.seizure.2021.05.017. Epub 2021 May 24. Seizure. 2021. PMID: 34090145
-
["Governor vessel daoqi method of acupuncture" combined with estazolam for insomnia: a randomized controlled trial].Zhongguo Zhen Jiu. 2018 May 12;38(5):4633-7. doi: 10.13703/j.0255-2930.2018.05.003. Zhongguo Zhen Jiu. 2018. PMID: 29797908 Review. Chinese.
Cited by
-
Transcutaneous vagus nerve stimulation for Parkinson's disease: a systematic review and meta-analysis.Front Aging Neurosci. 2025 Jan 14;16:1498176. doi: 10.3389/fnagi.2024.1498176. eCollection 2024. Front Aging Neurosci. 2025. PMID: 39877075 Free PMC article.
-
Effect of transcutaneous vagus nerve stimulation with electrical stimulation on generalized anxiety disorder: Study protocol for an assessor-participant blinded, randomized sham-controlled trial.Heliyon. 2025 Feb 6;11(4):e42469. doi: 10.1016/j.heliyon.2025.e42469. eCollection 2025 Feb 28. Heliyon. 2025. PMID: 40041000 Free PMC article.
-
Sleep links hippocampal propensity for epileptiform activity to its viscerosensory inputs.Front Neurosci. 2025 Mar 13;19:1559529. doi: 10.3389/fnins.2025.1559529. eCollection 2025. Front Neurosci. 2025. PMID: 40182148 Free PMC article.
-
Vagus Nerve Stimulation in Ischemic Stroke.Curr Neurol Neurosci Rep. 2023 Dec;23(12):947-962. doi: 10.1007/s11910-023-01323-w. Epub 2023 Nov 27. Curr Neurol Neurosci Rep. 2023. PMID: 38008851 Free PMC article. Review.
-
Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis.PLoS One. 2024 Nov 25;19(11):e0313101. doi: 10.1371/journal.pone.0313101. eCollection 2024. PLoS One. 2024. PMID: 39585887 Free PMC article.
References
-
- Williams A.B., Dzierzewski J.M., Griffin S.C., Lind M.J., Dick D., Rybarczyk B.D. Insomnia Disorder and Behaviorally Induced Insufficient Sleep Syndrome: Prevalence and Relationship to Depression in College Students. Behav. Sleep Med. 2020;18:275–286. doi: 10.1080/15402002.2019.1578772. - DOI - PMC - PubMed
-
- Zheng W., Luo X.-N., Li H.-Y., Ke X.-Y., Dai Q., Zhang C.-J., Ng C.H., Ungvari G.S., Xiang Y.-T., Ning Y.-P. Prevalence of insomnia symptoms and their associated factors in patients treated in outpatient clinics of four general hospitals in Guangzhou, China. BMC Psychiatry. 2018;18:232. doi: 10.1186/s12888-018-1808-6. - DOI - PMC - PubMed
-
- Ahmed A.E., Al-Jahdali H., Fatani A., Al-Rouqi K., Al-Jahdali F., Al-Harbi A., Baharoon S., Ali Y.Z., Khan M., Rumayyan A. The effects of age and gender on the prevalence of insomnia in a sample of the Saudi population. Ethn. Health. 2017;22:285–294. doi: 10.1080/13557858.2016.1244624. - DOI - PubMed
-
- Medina-Chávez J.H., Fuentes-Alexandro S.A., Gil-Palafox I.B., Adame-Galván L., Solís-Lam F., Sánchez-Herrera L.Y., Sánchez-Narváez F. Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly. Rev. Med. Inst. Mex. Seguro Soc. 2014;52:108–119. - PubMed
LinkOut - more resources
Full Text Sources
Medical